GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AMAG Pharmaceuticals Inc. (AMAG) [hlAlert]

Rating:
Buy AMAG
up 1.36 %

AMAG Pharmaceuticals Inc. (AMAG) upgraded to Buy with price target $80 by Jefferies

Posted on: Tuesday,  Aug 18, 2015  10:25 AM ET by Jefferies

Jefferies rated Buy AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) on 08/18/2015, when the stock price was $65.10. Since
then, AMAG Pharmaceuticals Inc. has gained 1.37% as of 01/25/2016's recent price of $65.99.
If you would have followed this Jefferies's recommendation on AMAG, you would have gained 1.36% of your investment in 160 days.

Advanced Materials Group Inc. develops, manufactures and markets a wide variety of industrial products. The company's principal subsidiary, Advanced Materials, Inc., is the successor to a business that converts specialty materials including foams, foils, films and adhesive composites into components and finished products such as printer cartridge inserts and inking felts, disk drive gaskets, automobile air conditioning insulators, water and dust seals, surgical pads and applicators for the medical, electronics, automotive and consumer products markets.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/18/2015 10:25 AM Buy
None
65.10 80.00
as of 8/27/2015
1 Week up  1.42 %
1 Month up  1.36 %
3 Months up  1.36 %
1 YTD up  1.36 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/23/2014 8:25 AM Hold
None
21.14 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy